11/10/2025
Exciting news for patients struggling with loose skin on their arms and abdomen! Contact us at 813.803.9111 for more info or to schedule a complimentary consultation.
——
We’re excited to announce that Ultherapy PRIME is now FDA-cleared to improve the appearance of skin laxity on the anterior arms, posterior arms, and abdomen.¹
These new indications expand the reach of our advanced ultrasound platform, based on the legacy of Ultherapy®, with over 3.5 million treatments performed worldwide.²
Ultherapy PRIME now brings clinically proven, non-invasive treatments to address the growing patient demand for solutions across both the face* and body**.²
By activating the skin’s collagen and elastin production precisely where it’s needed, Ultherapy PRIME—the only FDA-cleared microfocused ultrasound technology with vivid, real-time visualization — delivers personalized, natural-looking and long-lasting results†.³⁻⁷
One session. Zero downtime. Safe for all skin tones.¹
*Face refers to the FDA-cleared indications for Ultherapy PRIME
**Indicated to improve the appearance of skin laxity on the anterior arms, posterior arms, and abdomen
†Up to a year or more to lift the brow, skin under the chin, on the neck and smooth the décolleté, and 6 months or more to improve the appearance of skin laxity on the anterior and posterior arms and abdomen
To learn more, visit the link in bio
For safety information visit www.ultherapy.com/IFU.
Actual patient- posterior arms not treated.. Individual results may vary.
Sources:
1. Ulthera® Instructions for Use.
2. Merz Data on File
3. Fabi SG, Joseph J, Sevi J, et al.. J Drugs Dermatol. 2019;18(5):426-432.
4. Sasaki G, Tevez A. J Cosmet,Dermatol. 01/01 2012;02:108-116. doi:10.4236/jcdsa.2012.222022.
5. Marquardt K, Hartmann C, Wegener F, et al. J Cosmet Dermatol. 2025;24(1):e16638.
6. Sasaki G, Grossman J, Fabi SG, et al. Presented at the ASDS 2018 Annual Meeting.
7. Werschler WP, Werschler PS. J Clin Aesthet Dermatol. 2016;9(2):27-33.